Giu

[AHA Science @AHAScience]

📣: Fueled by ongoing increases in high blood pressure, obesity and other major risk factors, CVD remains leading cause of death as key health risk factors continue to rise

The 2025 Statistics Update is now available.

[Ronaldo Correa Fabiano @Ronaldo_CFF]

#AHA24

Prior studies: ⬆️vol. physical act (PA) linked ⬆️CAC in suggesting early atherosclerosis

Our findings:
⬆️Vol. PA was 🚫 linked w/ ⬆️CAC in asympt w/o CVD ELSA-Brasil cohort

Longitudinal athlete-level data is lacking

Thx my mentor @MBittencourtMD and all ELSA-Brasil

[Ronaldo Correa Fabiano @Ronaldo_CFF]

❤️‍🔥🩸

➡️What is the transfusion threshold in AMI with anemia?

Happy to share our meta-analysis!
#MINT

@MBittencourtMD @laramspc @nogueira_alleh @GewehrDM @generosoMD @RCardoso_MD
10.36660/abc.20240158

@ArquivosSBC @CircAHA @SVRaoMD @JDawnAbbott1 @docjohanne @AGoldsweig

[AHA Science @AHAScience]

1/ The 2024 Statistical Update is your comprehensive look at US and global data on heart and brain health, and an analysis of the core behaviors and conditions that affect CVD risk. Get the latest data published in @CIRCAHA:

https://t.co/AAdGhpEib3

✍🏼 @SethShayMartin

[Giu @generosoMD]

👏👏👏👏 @MBittencourtMD

[SOCESP @SocCardioESP]

O prof. da Universidade de Pittsburgh, Marcio Bittencourt, é mais um conferencista internacional que veio participar do Congresso da SOCESP. Ele debate o papel da tomografia computadorizada cardíaca e os avanços m relação à doença cardiovascular aterosclerótica em duas palestras.

[Raul Santos @rauldsf_santos]

These 2 weeks have been intensive but rewarding, hope I have contributed with a drop of water on the big ocean of preventive cardiology. Time to implement the knowledge !

[AHA Science @AHAScience]

1/ Hypertension, obesity & other risk factors continue to contribute to high rates of heart disease and stroke worldwide, including in the US, where annual CVD deaths are approaching 1M. Get the latest data published in @CIRCAHA:

https://t.co/6ub0z64Yy3

✍🏼 @SethShayMartin

[AHA Science @AHAScience]

1/ In 2021, 1.7M global deaths were attributed to diabetes, according to the 2024 Statistical Update, which also found that newer therapies proven to lower CVD risk remain underused. Get the latest data published in @CIRCAHA: https://t.co/yDYhRFbqme

✍🏼 @SethShayMartin

[NEJM @NEJM]

Dengue outbreaks can affect 390 million persons yearly. In a trial involving 16,235 persons in Brazil, the live, attenuated, tetravalent Butantan vaccine was efficacious in all age groups at 2 years. Read the full trial results: https://t.co/YY0iRP2Xqb

[Raul Santos @rauldsf_santos]

Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults | NEJM https://t.co/asED04hYG2 Proud and inspired by Brazilian scientists and investigators !

[Raul Santos @rauldsf_santos]

LDL-C–Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and Successes | Circulation https://t.co/D73QJwydIT Huge progress how to guarantee access? @dramitkhera @khurramn1

[AHA Science @AHAScience]

🆕 The 2024 Statistical Update is available now!

Heart disease remains the leading cause of death in U.S., yet fewer than half of adults surveyed knew it was their biggest health threat. Get the latest data here:

https://t.co/ohfrmOdbYq

[Marcio S Bittencourt @MBittencourtMD]

A diagnostic test can only have clinical implications if it leads to changes in patient management.
Our recent meta-analysis shows the changes in medications that occur after cardiac CT.
https://t.co/Sr0XTvyEb9

[Marcio S Bittencourt @MBittencourtMD]

Coronary CTA before planned invasive diagnostic cath might be routine for chronic CAD patients.
Doing a CTA in patients who would otherwise undergo cath is not only safe but it is also associated with more selective revascularizations and lower stroke rates!

[CircImaging @CircImaging]

#metaanalysis of 5,727 patients with chest pain referred for cath randomized to CCTA vs cath-first. CCTA was linked to lower rates of revasc and stroke compared to cath-first approach #AHAJournals https://t.co/ORLwsK5Cp0 @JiwonKimMD

[Giu @generosoMD]

@rauldsf_santos @Clarivate @FMUSPoficial @hosp_einstein Well deserved! You are an inspiration for us in Brazilian research.

[Mauricio Scanavacca @Scanav1Mauricio]

Early identification of oesophageal lesions after atrial fibrillation ablation to prevent atrio-oesophageal fistula https://t.co/b7KesiSBYT #Epeeps

[Ronaldo Correa Fabiano @Ronaldo_CFF]

A very special moment #AHA23, finally met in person most of our #ELSAbrasil team!!

@generosoMD @MBittencourtMD @RCardoso_MD @PauloLotufo Dr. Isabela Bensenor

[Pablo Corral MD @drpablocorral]

☝️All patients receiving statins (regardless of dose) should be associated with ezetimibe

👉Low cost
👉No side effects
👉20% LDLc reduction

[Marcio S Bittencourt @MBittencourtMD]

Outstanding work on calculated cardiovascular risk in the brazilian population from my friend @fernando_cesena

https://t.co/rpMWBzQHDo